212 related articles for article (PubMed ID: 31554669)
41. Ophthalmologic manifestations of acquired immune deficiency syndrome-associated progressive multifocal leukoencephalopathy.
Ormerod LD; Rhodes RH; Gross SA; Crane LR; Houchin KW
Ophthalmology; 1996 Jun; 103(6):899-906. PubMed ID: 8643245
[TBL] [Abstract][Full Text] [Related]
42. [Progressive multifocal leukoencephalopathy (PML) in chronic lymphatic leukemia (CLL). Review of the literature and case report].
Holzapfel C; Kellinghaus C; Lüttmann R; Zühlsdorf M; Burstedde V; Freund M; Husstedt IW
Nervenarzt; 2002 Jun; 73(6):543-7. PubMed ID: 12243002
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of progressive multifocal leukoencephalopathy treatments in a Spanish cohort of HIV-infected patients: do protease inhibitors improve survival regardless of central nervous system penetration-effectiveness (CPE) score?
Fanjul F; Riveiro-Barciela M; Gonzalez J; Delgado E; Murillas J; Payeras Cifré A; Falcó V; Riera M
HIV Med; 2013 May; 14(5):321-5. PubMed ID: 23217049
[TBL] [Abstract][Full Text] [Related]
44. Progressive multifocal leukoencephalopathy in Finland: a cross-sectional registry study.
Sipilä JOT; Soilu-Hänninen M; Rautava P; Kytö V
J Neurol; 2019 Feb; 266(2):515-521. PubMed ID: 30612143
[TBL] [Abstract][Full Text] [Related]
45. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
[TBL] [Abstract][Full Text] [Related]
46. Progressive multifocal leukoencephalopathy in HIV-infected patients in the era of HAART: radiological features at diagnosis and follow-up and correlation with clinical variables.
Giancola ML; Rizzi EB; Lorenzini P; Rovighi L; Baldini F; Schininà V; Larussa D; Bibbolino C; Antinori A
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):155-62. PubMed ID: 18240958
[TBL] [Abstract][Full Text] [Related]
47. [Progressive Multifocal Leukoencephalopathy Associated with HIV Infection Diagnosed by Brain Biopsy with Repeated Negative PCR Testing of CSF JC Virus DNA].
Kitazaki Y; Iwasaki H; Kitai R; Takahashi K; Nakamichi K; Hamano T
Brain Nerve; 2020 May; 72(5):541-546. PubMed ID: 32381752
[TBL] [Abstract][Full Text] [Related]
48. Progressive multifocal leukoencephalopathy in patients with HIV infection.
Berger JR; Pall L; Lanska D; Whiteman M
J Neurovirol; 1998 Feb; 4(1):59-68. PubMed ID: 9531012
[TBL] [Abstract][Full Text] [Related]
49. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy.
Koralnik IJ; Boden D; Mai VX; Lord CI; Letvin NL
Neurology; 1999 Jan; 52(2):253-60. PubMed ID: 9932940
[TBL] [Abstract][Full Text] [Related]
50. Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis.
De Luca A; Ammassari A; Pezzotti P; Cinque P; Gasnault J; Berenguer J; Di Giambenedetto S; Cingolani A; Taoufik Y; Miralles P; Marra CM; Antinori A;
AIDS; 2008 Sep; 22(14):1759-67. PubMed ID: 18753934
[TBL] [Abstract][Full Text] [Related]
51. Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy.
Hoepner R; Kolb EM; Dahlhaus S; Hellwig K; Adams O; Kleiter I; Salmen A; Schneider R; Lukas C; Chan A; Berger JR; Gold R
Mult Scler; 2017 May; 23(6):830-835. PubMed ID: 27600113
[TBL] [Abstract][Full Text] [Related]
52. A prominent lactate peak as a potential key magnetic resonance spectroscopy (MRS) feature of progressive multifocal leukoencephalopathy (PML): Spectrum pattern observed in three patients.
Kozić D; Bjelan M; Boban J; Ostojić J; Turkulov V; Todorović A; Lemajić-Komazec S; Brkić S
Bosn J Basic Med Sci; 2017 Nov; 17(4):349-354. PubMed ID: 28623673
[TBL] [Abstract][Full Text] [Related]
53. Predictors and characteristics of seizures in survivors of progressive multifocal leukoencephalopathy.
Miskin DP; Herman ST; Ngo LH; Koralnik IJ
J Neurovirol; 2016 Aug; 22(4):464-71. PubMed ID: 26676826
[TBL] [Abstract][Full Text] [Related]
54. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases.
Clifford DB; De Luca A; Simpson DM; Arendt G; Giovannoni G; Nath A
Lancet Neurol; 2010 Apr; 9(4):438-46. PubMed ID: 20298967
[TBL] [Abstract][Full Text] [Related]
55. Progressive multifocal leukoencephalopathy: a retrospective study of the last 12 years in a tertiary-care hospital.
Ligero-López J; Sánchez-Castellano MÁ; Falces-Romero I; Montero-Vega MD; García-Rodríguez J
J Neurovirol; 2023 Oct; 29(5):598-604. PubMed ID: 37470903
[TBL] [Abstract][Full Text] [Related]
56. [Progressive multifocal leukoencephalopathy in the province of Cadiz, Spain].
Gómez-González MB; Girón-González JA; Rodríguez-Iglesias MA; Pérez-Gracia MT
Rev Neurol; 2008 Sep 1-15; 47(5):231-5. PubMed ID: 18780267
[TBL] [Abstract][Full Text] [Related]
57. [The clinical spectrum of progressive multifocal leukoencephalopathy: differences and similarities in patients with and without human immunodeficiency virus].
Camporro J; Bruno V; Cammarota A; Del Castillo M; Alessandro L
Rev Neurol; 2019 Aug; 69(4):152-158. PubMed ID: 31334558
[TBL] [Abstract][Full Text] [Related]
58. [Progressive multifocal leukoencephalopathy (PML). Report of a case diagnosed by amplification of JC virus DNA from cerebrospinal fluid (CSF)].
Ito D; Yogo Y; Okita H; Tanaka K; Koto A
Rinsho Shinkeigaku; 1998 Jan; 38(1):46-50. PubMed ID: 9597910
[TBL] [Abstract][Full Text] [Related]
59. Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy.
Miralles P; Berenguer J; García de Viedma D; Padilla B; Cosin J; López-Bernaldo de Quirós JC; Muñoz L; Moreno S; Bouza E
AIDS; 1998 Dec; 12(18):2467-72. PubMed ID: 9875585
[TBL] [Abstract][Full Text] [Related]
60. Predictive value of JC virus PCR in cerebrospinal fluid in the diagnosis of PML.
Swinnen B; Saegeman V; Beuselinck K; Wouters A; Cypers G; Meyfroidt G; Schrooten M
Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114859. PubMed ID: 31320237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
